{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:29:27Z","timestamp":1786739367636,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"Abstract:<\/jats:title>\n \n OBJECTIVES:<\/jats:title>\n The objective of this study was to evaluate the efficacy and safety of tranexamic acid (TXA) nebulization to control bleeding in hemoptysis.<\/jats:p>\n <\/jats:sec>\n \n MATERIALS AND METHODS:<\/jats:title>\n In this randomized controlled clinical trial, 27 participants with hemoptysis received nebulization with TXA (500 mg\/5 mL, q 8 hourly for 2 days), and 29 participants with hemoptysis received nebulization with 0.9% normal saline (5 mL, q 8 hourly for 2 days) along with the standard therapy and followed up for 8 weeks.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n The mean percentage decrease in the frequency (63.9% vs. 39.8%,\n P<\/jats:italic>\n = 0.012) and quantity (73.4% vs. 51.7%,\n P<\/jats:italic>\n = 0.024) of hemoptysis was significantly higher in the TXA group compared to the control group at day 1 but was insignificant at day 2. However, after excluding participants who underwent intervention (\n N<\/jats:italic>\n = 11), the improvement in frequency (76.2% vs. 50.3%,\n P<\/jats:italic>\n = 0.049) and quantity (85.2% vs. 58.6%,\n P<\/jats:italic>\n = 0.021) of hemoptysis was significantly better in the TXA group even at day 2. Out of 56 participants, 24 participants achieved resolution of hemoptysis, which was also significantly (\n P<\/jats:italic>\n = 0.003) better in the TXA group (63.0%) compared to the control group (24.1%). No serious adverse drug reaction was observed. Minor cough (37.5%) and throat irritation (33.9%) were observed, which were comparable (\n P<\/jats:italic>\n = 0.432) between the groups.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n TXA nebulization, an alternative route of administration, was found to be safe. Prompt nebulization with TXA was effective as bridging therapy in hemoptysis to achieve the immediate goal of bleeding control before definitive intervention planned or performed. Further studies are encouraged to evaluate this novel approach of TXA nebulization. Trial registration: clinicaltrials.gov PRS ID: NCT05648656.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijp.ijp_824_25","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:00:09Z","timestamp":1762941609000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of tranexamic acid nebulization to control bleeding of hemoptysis: The TXA-NEB randomized controlled clinical trial"],"prefix":"10.4103","volume":"57","author":[{"given":"Aman","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deba Prasad","family":"Dhibar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B C","family":"Sreedhara","sequence":"additional","affiliation":[{"name":"Department of Radio Diagnosis and Imaging, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valliappan","family":"Muthu","sequence":"additional","affiliation":[{"name":"Department Pulmonary Medicine, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Pannu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,12]]},"reference":[{"key":"R1-20251112","first-page":"243","article-title":"Hemoptysis:Evaluation and management","volume":"91","author":"Earwood","year":"2015","journal-title":"Am Fam Physician"},{"key":"R2-20251112","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.athoracsur.2008.11.010","article-title":"Multidisciplinary management of life-threatening massive hemoptysis:A 10-year experience","volume":"87","author":"Shigemura","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R3-20251112","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid:A review of its use in surgery and other indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2016.07.006","article-title":"Efficacy of tranexamic acid in haemoptysis:A randomized, controlled pilot study","volume":"40","author":"Bellam","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/LBR.0b013e3181dc8c17","article-title":"Endobronchial administration of tranexamic acid for controlling pulmonary bleeding:A pilot study","volume":"17","author":"M\u00e1rquez-Mart\u00edn","year":"2010","journal-title":"J Bronchology Interv Pulmonol"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment:A randomized controlled trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12245-020-00304-x","article-title":"Nebulized tranexamic acid for recurring hemoptysis in critically ill patients:Case series","volume":"13","author":"Alabdrabalnabi","year":"2020","journal-title":"Int J Emerg Med"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4103\/ijmy.ijmy_54_17","article-title":"Etiology and outcome of moderate-to-massive hemoptysis:Experience from a tertiary care center of North India","volume":"6","author":"Bhalla","year":"2017","journal-title":"Int J Mycobacteriol"},{"key":"R9-20251112","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.chest.2022.11.021","article-title":"Nebulized versus IV tranexamic acid for hemoptysis:A pilot randomized controlled trial","volume":"163","author":"Gopinath","year":"2023","journal-title":"Chest"},{"key":"R10-20251112","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40261-020-00946-y","article-title":"Effects of tranexamic acid on hemoptysis:A systematic review and meta-analysis of randomized controlled trials","volume":"40","author":"Tsai","year":"2020","journal-title":"Clin Drug Investig"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"e25898","DOI":"10.1097\/MD.0000000000025898","article-title":"Does tranexamic acid reduce risk of mortality on patients with hemoptysis?A protocol for systematic review and meta-analysis","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/TH03-03-0152","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13256-020-02545-z","article-title":"Bilateral pulmonary embolism while receiving tranexamic acid:A case report","volume":"14","author":"Ijaopo","year":"2020","journal-title":"J Med Case Rep"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_824_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:23Z","timestamp":1786735703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_824_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_824_25","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,12]]},"assertion":[{"value":"2025-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}